{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:53Z","timestamp":1790337833484,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401850"],"award-info":[{"award-number":["82401850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020226","name":"Hunan Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022JJ30075"],"award-info":[{"award-number":["2022JJ30075"]}],"id":[{"id":"10.13039\/501100020226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2023SK2023"],"award-info":[{"award-number":["2023SK2023"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103528","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:06:49Z","timestamp":1786284409000},"page":"103528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor microenvironment-rearranging Nanoassemblies overcome angiogenesis-immunotherapy resistance to potentiate osteosarcoma treatment"],"prefix":"10.1016","volume":"40","author":[{"given":"Zili","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-3469","authenticated-orcid":false,"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103528_bib1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(19)30825-3","article-title":"Cabozantinib in patients with advanced ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial","volume":"21","author":"Italiano","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mtbio.2026.103528_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41419-022-04620-3","article-title":"Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition","volume":"13","author":"Wang","year":"2022","journal-title":"Cell death & disease"},{"key":"10.1016\/j.mtbio.2026.103528_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11864-022-00990-0","article-title":"Regorafenib for the treatment of sarcoma","volume":"23","author":"Blay","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.mtbio.2026.103528_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/thno.21674","article-title":"Current challenges of cancer anti-angiogenic therapy and the promise of nanotherapeutics","volume":"8","author":"Abdalla","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103528_bib5","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","article-title":"Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy","volume":"15","author":"Ebos","year":"2009","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.mtbio.2026.103528_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103528_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169150","article-title":"Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration","volume":"9","author":"Liu","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.mtbio.2026.103528_bib8","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1158\/1078-0432.CCR-23-0257","article-title":"Regorafenib plus vincristine and Irinotecan in pediatric patients with recurrent\/refractory solid tumors: an innovative therapy for children with cancer study","volume":"29","author":"Casanova","year":"2023","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.mtbio.2026.103528_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","article-title":"Innate immunity and cancer pathophysiology","volume":"17","author":"Maiorino","year":"2022","journal-title":"Annual review of pathology"},{"key":"10.1016\/j.mtbio.2026.103528_bib11","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103528_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","article-title":"Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs","volume":"500","author":"Chen","year":"2021","journal-title":"Cancer letters"},{"key":"10.1016\/j.mtbio.2026.103528_bib13","article-title":"Single-cell RNA-Seq reveals T cell exhaustion and immune response landscape in osteosarcoma","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib14","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103528_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid immunosuppression and immune checkpoints in the tumor microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fimmu.2020.00783","article-title":"Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors","volume":"11","author":"Hou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103528_bib19","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/ITT.S485672","article-title":"Myeloid cells in the immunosuppressive microenvironment as immunotargets in osteosarcoma","volume":"14","author":"Sholevar","year":"2025","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.mtbio.2026.103528_bib21","article-title":"Promise and challenges of T cell immunotherapy for osteosarcoma","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103528_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.32604\/or.2024.056860","article-title":"Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma","volume":"33","author":"Ka","year":"2025","journal-title":"Oncology research"},{"key":"10.1016\/j.mtbio.2026.103528_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202005155","article-title":"Monotherapy and combination therapy using anti-angiogenic nanoagents to fight cancer","volume":"33","author":"Liang","year":"2021","journal-title":"Advanced materials (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.mtbio.2026.103528_bib24","first-page":"64","article-title":"Conformationally regulated \"nanozyme-like\" cerium oxide with multiple free radical scavenging activities for osteoimmunology modulation and vascularized osseointegration","volume":"34","author":"Bao","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2026.103528_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-023-02182-w","article-title":"Nanocomposites based on nanoceria regulate the immune microenvironment for the treatment of polycystic ovary syndrome","volume":"21","author":"Yan","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103528_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12951-025-03594-6","article-title":"Intravesical delivery of mucoadhesive and tumor-selective-penetrating nanozymes for enhancing the PDT of bladder cancer","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103528_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.actbio.2024.09.045","article-title":"A biphasic drug-releasing microneedle with ROS scavenging and angiogenesis for the treatment of diabetic ulcers","volume":"189","author":"He","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.103528_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202102342","article-title":"Redox active cerium oxide nanoparticles: current status and burning issues","volume":"17","author":"Lord","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103528_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12951-025-03187-3","article-title":"Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103528_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/pharmaceutics15041309","article-title":"Cerium end-deposited gold nanorods-based photoimmunotherapy for boosting tumor immunogenicity","volume":"15","author":"Feng","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103528_bib31","article-title":"ROS scavenging nanozyme modulates immunosuppression for sensitized cancer immunotherapy","volume":"12","author":"Mo","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103528_bib32","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1021\/acsnano.5c02860","article-title":"Scavenging reactive oxygen species by cerium oxide nanoparticles prevents death in a peripheral T cell lymphoma preclinical mouse model","volume":"19","author":"Krug","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103528_bib33","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.mtbio.2026.103528_bib34","article-title":"TAM-hijacked immunoreaction rescued by hypoxia-pathway-intervened strategy for enhanced metastatic cancer immunotherapy","volume":"20","author":"Jiang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103528_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406860","article-title":"Dual oxygen-supply immunosuppression-inhibiting nanomedicine to avoid the intratumoral recruitment of myeloid-derived suppressor cells","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103528_bib36","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.2147\/IJN.S521372","article-title":"Therapeutic potential of PDA@CeO2 in suppressing hepatic stellate cell activation and preventing liver fibrosis","volume":"20","author":"Li","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103528_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2013.06.004","article-title":"A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis","volume":"24","author":"Masiero","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103528_bib38","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/ijms23073817","article-title":"Recent and ongoing research into metastatic osteosarcoma treatments","volume":"23","author":"Harris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103528_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103528_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-Mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mtbio.2026.103528_bib41","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954463","article-title":"Targeting hypoxia at the forefront of anticancer immune responses","volume":"3","author":"Noman","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.mtbio.2026.103528_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202531547","article-title":"Hyaluronic acid-coated DNA nanoflowers as smart nanocarriers for deep tumor penetration and enhanced gene therapy in pancreatic cancer","volume":"36","author":"You","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2026.103528_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2021.08.179","article-title":"Improving regorafenib's organ target precision via nano-assembly to change its delivery mode abolishes chemoresistance and liver metastasis of colorectal cancer","volume":"607","author":"Liu","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.103528_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.colsurfb.2017.02.006","article-title":"Evaluation of molecular chaperone drug function: regorafenib and \u03b2-cyclodextrins","volume":"153","author":"Hu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2026.103528_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113652","article-title":"Regorafenib induces damage-associated molecular patterns, cancer cell death and immune modulatory effects in a murine triple negative breast cancer model","volume":"429","author":"Tseng","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mtbio.2026.103528_bib46","doi-asserted-by":"crossref","first-page":"19260","DOI":"10.1021\/acsami.5b05185","article-title":"Label-free electrochemiluminescent immunosensor for detection of carcinoembryonic antigen based on nanocomposites of GO\/MWCNTs-COOH\/Au@CeO2","volume":"7","author":"Pang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103528_bib47","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acs.molpharmaceut.7b00920","article-title":"Targeted delivery and redox activity of folic acid-functionalized nanoceria in tumor cells","volume":"15","author":"Vassie","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2026.103528_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2023.09.002","article-title":"Targeting intratumoral hypoxia to enhance anti-tumor immunity","volume":"96","author":"Semenza","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.mtbio.2026.103528_bib49","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"Xia","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103528_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-Mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103528_bib51","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103528_bib52","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103528_bib53","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/jacs.7b02396","article-title":"Overcoming the limits of hypoxia in photodynamic therapy: a carbonic anhydrase IX-Targeted approach","volume":"139","author":"Jung","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103528_bib54","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib55","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103528_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103528_bib57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103528_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808200","article-title":"Biomimetic metal-organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy","volume":"31","author":"Min","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103528_bib60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.mtbio.2026.103528_bib61","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.mtbio.2026.103528_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature21724","article-title":"Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming","volume":"544","author":"Tian","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103528_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7080097","article-title":"Cerium oxide nanoparticles: a brief review of their synthesis methods and biomedical applications","volume":"7","author":"Dhall","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2026.103528_bib64","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/pharmaceutics17111475","article-title":"Biodistribution and toxicological impact assessment of cerium dioxide nanoparticles in murine models: a systematic review of in vivo and Ex vivo studies","volume":"17","author":"Lazareva","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103528_bib65","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","article-title":"Hyaluronan-CD44 interactions as potential targets for cancer therapy","volume":"278","author":"Misra","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.mtbio.2026.103528_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17111475","article-title":"Biodistribution and toxicological impact assessment of cerium dioxide nanoparticles in murine models: a systematic review of in vivo and Ex vivo studies","volume":"17","author":"Lazareva","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103528_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102302","article-title":"Cerium oxide nanoparticles, physical and chemical properties, applications and toxicological implications: a review","volume":"15","author":"Mohajeri","year":"2025","journal-title":"Results Chem."},{"key":"10.1016\/j.mtbio.2026.103528_bib68","article-title":"Advanced biomedical applications of cerium oxide nanoparticles: intrinsic property\u2013driven therapeutic multifunctionality, drug delivery system design and toxicological assessment","volume":"49","author":"Liu","year":"2025","journal-title":"Mater. Today Chem."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:46:10Z","timestamp":1790336770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S2590006426007738"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103528","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment-rearranging Nanoassemblies overcome angiogenesis-immunotherapy resistance to potentiate osteosarcoma treatment","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103528"}}